The Addition of Clonidine to 0.2% Ropivacaine for Wound Instillation After Minor Lower Abdominal Surgery in Children

Sponsor
Children's Hospital of Eastern Ontario (Other)
Overall Status
Completed
CT.gov ID
NCT00130091
Collaborator
(none)
120
1
2
63
1.9

Study Details

Study Description

Brief Summary

The current study will compare the effects on postoperative pain relief of "freezing" (ropivacaine 0.2 %) alone and in combination with clonidine for a nerve block in children undergoing hernia repair. The researchers anticipate that the addition of clonidine to "freezing" will result in prolongation of postoperative pain relief in children undergoing hernia repair compared to "freezing" used alone.

Condition or Disease Intervention/Treatment Phase
Phase 2

Detailed Description

The optimal method of controlling postoperative pain in children undergoing hernia repair would effectively relieve pain for extended periods of time and have no adverse effects. Unfortunately, such an ideal technique does not exist.

The control of postoperative pediatric pain after hernia repair is achieved with a combination of oral and intravenous pain medications and "nerve blocks". "Nerve blocks" are achieved by injecting local anesthetics or what is commonly referred to as "freezing "next to the nerve supply of the wound. "Freezing" the major nerves supplying sensation at the site of hernia repair in children, while they are asleep, is effective. At CHEO, this technique in addition to administering ketorolac, a liquid intravenous form of an anti-inflammatory agent similar to Advil, is the current technique of choice for postoperative pain control after inguinal hernia.

It is not unusual for these patients to require extra pain medications postoperatively. Available means of pain control in addition to those mentioned above include codeine-like medications, Tylenol, Advil-like medications and opioids administered intravenously. The addition of these medications increases the risk of suffering from side effects including respiratory depression, nausea and vomiting, and itching.

Ideally, the prolongation of postoperative pain relief by the addition of a second medication to the "freezing" during the nerve block would limit the need for additional pain medication and hence, decrease their associated side effects. Clonidine has the potential to be such a medication. It has been shown to provide pain relief by affecting several areas of the nervous system including the brain, the spinal cord and nerves. Clonidine prolongs pain relief of certain local anesthetics when used in nerve blocks for adults. Unfortunately, there are no studies that have examined the combination of clonidine and the local anesthetic ropivacaine for nerve blocks in children. Presently, the injectable form of clonidine is not marketed and is considered investigational in Canada.

The current study will be a prospective double -blind, randomized, controlled trial. It will compare the effects on postoperative pain relief of "freezing" (ropivacaine 0.2 %) alone and in combination with clonidine for a nerve block in children undergoing hernia repair. In addition, it will measure changes in the child's level of sedation, breathing, heart rate, blood pressure and any complications. Finally, it will assess how satisfied the parents are with this technique.

The researchers anticipate that the addition of clonidine to "freezing" will result in prolongation of postoperative pain relief in children undergoing hernia repair compared to "freezing" used alone.

Study Design

Study Type:
Interventional
Actual Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Addition of Clonidine to 0.2% Ropivacaine for Wound Instillation After Minor Lower Abdominal Surgery in Children
Study Start Date :
Sep 1, 2009
Actual Primary Completion Date :
Feb 1, 2014
Actual Study Completion Date :
Dec 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: Clonidine

administer with local anesthetic

Drug: clonidine
2 mcg clonidine added to local anesthetic

Placebo Comparator: Local anesthetic

Local anesthetic without clonidine

Drug: clonidine
2 mcg clonidine added to local anesthetic

Outcome Measures

Primary Outcome Measures

  1. Time to first analgesia after procedure [24 hours]

Secondary Outcome Measures

  1. continuous pain scores (modified Children's Hospital of Eastern Ontario Pain Score [mCHEOPS], modified Wong-Baker Faces) [baseline plus seven days]

  2. sedation scores [Between surgery and surgical day unit discharge (approx four hours)]

  3. emergence delirium score (Pediatric Anesthesia Emergence Delirium [PAED]) [Between surgery and surgical day unit discharge (approx four hours)]

  4. total analgesics consumed [seven days]

  5. total sedation consumed [Between surgery and surgical day unit discharge (approx four hours)]

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Year to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Unilateral inguinal hernia or hydrocele

  • 1 to 12 years old

  • American Society of Anesthesiology classification I-II

  • Written informed consent

Exclusion Criteria:
  • Exclusion to nerve block

  • Clotting disorder

  • Infection

  • Known allergy to clonidine or ropivacaine

  • History of chronic, therapeutic administration of analgesics

  • Receiving medications for attention deficit hyperactivity disorder

  • Patients taking oral clonidine

  • Undergoing bilateral hernia repair

  • Morbid obesity

Contacts and Locations

Locations

Site City State Country Postal Code
1 Children's Hospital of Eastern Ontario Ottawa Ontario Canada K1H 8L1

Sponsors and Collaborators

  • Children's Hospital of Eastern Ontario

Investigators

  • Principal Investigator: Kimmo Murto, MD, Children's Hospital of Eastern Ontario

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kimmo Murto, MD, FRCPC, Dept. Anesthesiology CHEO, Assistant Professor, University of Ottawa, Children's Hospital of Eastern Ontario
ClinicalTrials.gov Identifier:
NCT00130091
Other Study ID Numbers:
  • 05/17E
First Posted:
Aug 15, 2005
Last Update Posted:
Feb 20, 2015
Last Verified:
Feb 1, 2015
Keywords provided by Kimmo Murto, MD, FRCPC, Dept. Anesthesiology CHEO, Assistant Professor, University of Ottawa, Children's Hospital of Eastern Ontario
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 20, 2015